Unity Biotechnology Net Interest Income Over Time
| UBX Stock | USD 1.14 0.02 1.72% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Unity Biotechnology Performance and Unity Biotechnology Correlation. Unity |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Unity Biotechnology. If investors know Unity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Unity Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.28) | Quarterly Revenue Growth (1.00) | Return On Assets (0.30) | Return On Equity (0.87) |
The market value of Unity Biotechnology is measured differently than its book value, which is the value of Unity that is recorded on the company's balance sheet. Investors also form their own opinion of Unity Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Unity Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Unity Biotechnology's market value can be influenced by many factors that don't directly affect Unity Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Unity Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Unity Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Unity Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Interest Income Analysis
Compare Unity Biotechnology and related stocks such as Exscientia ADR, Recursion Pharmaceuticals, and Atea Pharmaceuticals Net Interest Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RXRX | 1.1 M | 1.1 M | 1.1 M | 1.1 M | 1.1 M | 1.1 M | 1.1 M | 1.1 M | 1.1 M | 1.1 M | (1 M) | (2.9 M) | 6.2 M | 18.2 M | 19.1 M |
| AVIR | 413 K | 413 K | 413 K | 413 K | 413 K | 413 K | 413 K | 413 K | 413 K | 574 K | 83 K | 213 K | 11.2 M | 29.2 M | 30.7 M |
| HOOK | (606 K) | (606 K) | (606 K) | (606 K) | (606 K) | (606 K) | (606 K) | (606 K) | (778 K) | 710 K | (386 K) | (871 K) | 946 K | 4.6 M | 4.8 M |
| ABOS | 45 K | 45 K | 45 K | 45 K | 45 K | 45 K | 45 K | 45 K | 45 K | 45 K | 1000 | 84 K | 2.4 M | 8.2 M | 8.6 M |
| HRTX | (2.7 M) | (2.7 M) | (2.7 M) | (2.7 M) | (2.7 M) | (2.7 M) | (2.7 M) | (2.9 M) | 3.3 M | 5.8 M | 1.7 M | (2 M) | (836 K) | (504 K) | (478.8 K) |
| RNA | (718 K) | (718 K) | (718 K) | (718 K) | (718 K) | (718 K) | (718 K) | (718 K) | (718 K) | (7.4 M) | (3 K) | 104 K | 5 M | 20.3 M | 21.4 M |
| BEAM | 292 K | 292 K | 292 K | 292 K | 292 K | 292 K | 292 K | 292 K | 292 K | 2.3 M | 1.6 M | (9 K) | 15.3 M | 42.2 M | 44.3 M |
| NTLA | 525 K | 525 K | 525 K | 525 K | 525 K | 525 K | 525 K | 2 M | 5.5 M | 6.8 M | 2.4 M | 1.3 M | 8.5 M | 49.8 M | 52.3 M |
| EDIT | 62 K | 62 K | 62 K | 62 K | 62 K | 62 K | 62 K | (978 K) | 3.4 M | 7.3 M | 2.6 M | 2.3 M | 4.2 M | 13.9 M | 14.6 M |
| VERV | 278 K | 278 K | 278 K | 278 K | 278 K | 278 K | 278 K | 278 K | 278 K | 278 K | 162 K | 142 K | 6.9 M | 21.3 M | 22.4 M |
| WINT | (2.5 M) | (2.5 M) | (2.5 M) | (2.5 M) | (2.5 M) | (2.5 M) | (2.5 M) | (1.9 M) | (1.4 M) | (342 K) | (3 K) | (23 K) | 56 K | 275 K | 288.8 K |
| DRMA | (250.7 K) | (250.7 K) | (250.7 K) | (250.7 K) | (250.7 K) | (250.7 K) | (250.7 K) | (250.7 K) | (250.7 K) | (250.7 K) | (197.3 K) | (45.6 K) | 63.6 K | 203.4 K | 213.6 K |
| ENSC | (995.5 K) | (995.5 K) | (995.5 K) | (995.5 K) | (995.5 K) | (995.5 K) | (995.5 K) | (995.5 K) | (995.5 K) | (995.5 K) | (995.5 K) | (5.1 M) | (5 M) | (80 K) | (84 K) |
| NUVB | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 3 M | 7.4 M | 24.6 M | 25.8 M |
| OVID | 120.8 K | 120.8 K | 120.8 K | 120.8 K | 120.8 K | 120.8 K | 120.8 K | 201.5 K | 952.1 K | 948.2 K | 4.9 M | 4.9 M | 4.9 M | 5.6 M | 5.9 M |
| CNTB | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | (2.2 M) | 578 K | 10.6 M | 2.7 M | 2.8 M |
Unity Biotechnology and related stocks such as Exscientia ADR, Recursion Pharmaceuticals, and Atea Pharmaceuticals Net Interest Income description
The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.My Equities
My Current Equities and Potential Positions
| Unity Biotechnology | UBX |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 1.14
Additional Tools for Unity Stock Analysis
When running Unity Biotechnology's price analysis, check to measure Unity Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Unity Biotechnology is operating at the current time. Most of Unity Biotechnology's value examination focuses on studying past and present price action to predict the probability of Unity Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Unity Biotechnology's price. Additionally, you may evaluate how the addition of Unity Biotechnology to your portfolios can decrease your overall portfolio volatility.